DelMar Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.31 |
Market Cap |
$4 M |
Shares Outstanding |
3.83 M |
Public Float |
23.61 M |
Address |
999 West Broadway Vancouver British Columbia V5Z 1K5 Canada |
Employees | - |
Website | http://www.delmarpharma.com |
Updated | 07/08/2019 |
DelMar Pharmaceuticals, Inc. is a clinical and commercial stage drug development company, which focuses on the research and development of drugs for the treatment of cancer. It offers VAL-083; drug discovery research; as well as patents and intellectual property. The company was founded by Jeffrey A. |